Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 12, 2019
Mon, February 11, 2019
[ Mon, Feb 11th 2019
] - WOPRAI
[ Mon, Feb 11th 2019
] - WOPRAI
[ Mon, Feb 11th 2019
] - WOPRAI
[ Mon, Feb 11th 2019
] - WOPRAI
[ Mon, Feb 11th 2019
] - WOPRAI
[ Mon, Feb 11th 2019
] - WOPRAI
[ Mon, Feb 11th 2019
] - WOPRAI
[ Mon, Feb 11th 2019
] - WOPRAI
[ Mon, Feb 11th 2019
] - WOPRAI
[ Mon, Feb 11th 2019
] - WOPRAI
[ Mon, Feb 11th 2019
] - WOPRAI
Fri, February 8, 2019
[ Fri, Feb 08th 2019
] - WOPRAI
[ Fri, Feb 08th 2019
] - WOPRAI
[ Fri, Feb 08th 2019
] - WOPRAI
[ Fri, Feb 08th 2019
] - WOPRAI
[ Fri, Feb 08th 2019
] - WOPRAI
Thu, February 7, 2019
[ Thu, Feb 07th 2019
] - WOPRAI
[ Thu, Feb 07th 2019
] - WOPRAI
[ Thu, Feb 07th 2019
] - WOPRAI
Raghuram Selvaraju Initiated (ADMA) at Strong Buy and Held Target at $10 on, Feb 7th, 2019
Raghuram Selvaraju of HC Wainwright & Co., Initiated "ADMA Biologics, Inc." (ADMA) at Strong Buy and Held Target at $10 on, Feb 7th, 2019.
Raghuram has made no other calls on ADMA in the last 4 months.
There is 1 other peer that has a rating on ADMA. Out of the 1 peers that are also analyzing ADMA, 0 agree with Raghuram's Rating of Hold.
This is the rating of the analyst that currently disagrees with Raghuram
- Reni Benjamin of "Raymond James" Maintained at Buy with Decreased Target to $10 on, Friday, October 12th, 2018
Similar Stocks and Investing Articles
[ Tue, Oct 30th 2018
] - WOPRAI
[ Fri, Oct 12th 2018
] - WOPRAI
[ Thu, Oct 11th 2018
] - WOPRAI
[ Thu, Jul 12th 2018
] - WOPRAI
[ Fri, Jan 26th 2018
] - WOPRAI
[ Mon, Nov 27th 2017
] - WOPRAI
[ Fri, Oct 06th 2017
] - WOPRAI
[ Fri, Jan 15th 2016
] - WOPRAI
[ Tue, Feb 24th 2015
] - WOPRAI